Elite Pharmaceuticals Inc (ELTP)

[Couch]

Nice find! And nice overview of the issues at hand. The quoted sentence below highlights one of the points that I've made previously. Elite has a novel pharmacologic ADT - how is society and the FDA going to tell if it actually detours abuse over an extended period of time?? They are going to have to approve it and wait for the post-marketing results to fully answer this question.

Plus, even if the opioid reduces snorting and injecting it that is way better than an ER easily abused Roxy that one can snort and inject.

What has more street value Opana or Pfizer's Troxyca - clearly Opana and it will also cost society at large way more in expenses to addiction than Troxyca will......but then again that's what the postmarking studies will be asked to prove.

"This technology is already on the market," Campopiano said. "We have the opportunity to make a better informed decision if we wait for that postmarketing data."